We will review the clinical features, diagnosis, and management of acquired hemophilia A (AHA), share the clinical study data supporting the indication of OBIZUR for treatment of bleeding episodes in adults with AHA, and discuss patient cases in which OBIZUR may be an appropriate treatment option.

This presentation will review the use of Idelvion on demand for patients. It is a clinical presentation.

Date: Thur, March 18 and 19th, 2021 12:00 PM - 5:00 PM EST - Register Here (Please register individually for…

• 340B Basics – a discussion on what the 340B pharmacy program is and the importance to HTCs and the bleeding disorders community.
• Collaboration efforts between HTCs and local Chapters – we will share 2 successful collaboration stories, highlighting program development to benefit the bleeding disorders community.
• HTC Wall of Walkers Challenge – aimed at increasing HTC participation in NHFs Unite Walk program. We will also discuss Walks not affiliated with the NHF program. This initiative will build upon the primary goal of Harmony in Hemophilia which is to enhance or build relationships between HTCs and Chapters.

Date: Thur, April 22, 2021 1:00 PM - 2:00 PM EST - Register Here Target Audience: HTC Staff